"Parkiet's" cites the experts, in the issue of 21st July, in whose opinion the financial results of the most companies from the WIG20, are likely to disappoint the investors, though middle size and small companies, profiting from the economic revival, may positively surprise. NEUCA as the only one wholesaler of pharmaceuticals is cited among the ten companies that are expected to show the above-average results by the market. The factors that accelerate the business growth of NEUCA are: a growing pharmaceutical market in Poland, development of new businesses and growing sale of private label products.

Neuca SA published this content on 21 July 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 01 August 2016 14:31:05 UTC.

Original documenthttp://www.neuca.pl/en/news-single/609/neuca-in-the-strong-ten-of-the-q2?lastCategory=all

Public permalinkhttp://www.publicnow.com/view/F3DAEBA6466CC6D6EA1CB0EEFA4C750AB798CB15